View Older Stories

Oct 6, 2025 05:27AM Rocket Pharmaceuticals (RCKT) PT Lowered to $7 at Leerink Partners

Oct 3, 2025 04:36PM Rocket Pharmaceuticals board member Pedro Granadillo resigns

Oct 3, 2025 10:35AM Rocket Pharmaceuticals (RCKT) PT Lowered to $7 at Leerink Partners

Oct 3, 2025 07:06AM Rocket Pharmaceuticals withdraws gene therapy application from FDA

Sep 22, 2025 07:21AM Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)

Aug 28, 2025 09:52AM Rocket Pharmaceuticals (RCKT) Director Reported Purchase of Stock Last Night

Aug 25, 2025 04:12PM Rocket Pharmaceuticals CFO Aaron Ondrey to resign September 5

Aug 21, 2025 06:22AM Canaccord Genuity Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT)

Aug 20, 2025 02:11PM Goldman Sachs Reiterates Sell Rating on Rocket Pharmaceuticals (RCKT), PT $2,

Aug 20, 2025 01:58PM BofA Securities Upgrades Rocket Pharmaceuticals (RCKT) to Buy, 'Lift removes key uncertainty, setting up path to re-rating'

Aug 8, 2025 05:35AM Rocket Pharmaceuticals (RCKT) PT Raised to $3 at Jefferies

Aug 7, 2025 09:25AM RCKT 4-DAY DEADLINE ALERT: FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

Jul 29, 2025 03:05PM Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman

Jul 25, 2025 06:34AM Rocket Pharmaceuticals (RCKT) PT Lowered to $10 at Canaccord Genuity

Jul 25, 2025 06:14AM BofA Securities Downgrades Rocket Pharmaceuticals (RCKT) to Neutral

Jul 24, 2025 07:00AM Rocket Pharmaceuticals cuts workforce 30% to focus on heart treatments

Jul 23, 2025 04:31PM Rocket Pharmaceuticals (RCKT) to cut 30% staff

Jul 22, 2025 05:25PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 22, 2025 05:05PM ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 22, 2025 03:51PM Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 22, 2025 12:38PM FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

Jul 21, 2025 05:00PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 20, 2025 05:00PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 20, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 19, 2025 03:24PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 19, 2025 08:05AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 18, 2025 03:19PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 18, 2025 01:07PM INVESTOR REMINDER: Berger Montague Notifies Rocket Pharmaceuticals (RCKT) Investors of a Class Action Lawsuit and Deadline

Jul 18, 2025 12:27PM FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

Jul 18, 2025 06:15AM RCKT INVESTOR DEADLINE: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Jul 17, 2025 03:13PM ROSEN, A LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 17, 2025 07:00AM Rocket Pharmaceuticals receives FDA RMAT designation for heart gene therapy

Jul 16, 2025 04:16PM CLASS ACTION NOTICE: Berger Montague Advises Rocket Pharmaceuticals (RCKT) Investors to Inquire About a Securities Fraud Class Action

Jul 15, 2025 12:17PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 15, 2025 08:30AM Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman

Jul 14, 2025 05:11PM Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns

Jul 14, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 14, 2025 12:30PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 14, 2025 12:15PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 13, 2025 07:59AM Faruqi & Faruqi Notifies Rocket Pharmaceuticals Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT

Jul 12, 2025 02:24PM ROSEN, A LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 11, 2025 02:33PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 10, 2025 04:51PM Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT)

Jul 9, 2025 05:36PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 9, 2025 02:25PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 8, 2025 07:08PM Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman

Jul 8, 2025 05:31PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 8, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 7, 2025 07:15PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 7, 2025 02:30AM RCKT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

View Older Stories